BIO Integration journal, Volume 1, Issue number 4, publishes

Guangzhou, January 15, 2021: New journal BIO Integration (BIOI) publishes its fourth issue, volume 1, issue 4. BIOI is a peer-reviewed, open access, international journal, which is dedicated to spreading multidisciplinary views driving the advancement of modern medicine. Aimed at bridging the gap between the laboratory, clinic, and biotechnology industries, it will offer a cross-disciplinary…

Details

Increased risk of Parkinson’s disease in patients with schizophrenia

A new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson’s disease later in life. The increased risk may be due to alterations in the brain’s dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia. The record-based case-control study…

Details

Çukurova University (TDRAC) joins Bentham Science as institutional member

Bentham Science is pleased to announce an Institutional Member partnership with the Turkish university, Çukurova University Tropical Diseases Research and Application Center (TDRAC). The partnership provides the opportunity to the researchers, from the university, to publish their research under an Open Access license with specified fee concessions. This agreement is a continuation of Bentham Science…

Details

IOF and IFCC review calls for harmonization of assays for reference bone turnover markers

Bone turnover markers (BTMs) in blood and urine are useful tools in monitoring osteoporosis treatment effects and may be useful for improving patient adherence. In 2011, a Joint Committee on Bone Metabolism of the International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) designated Procollagen type I N-propeptide (PINP)…

Details

CHOP researchers Find NTRK fusions more common than expected in pediatric tumors

Philadelphia, January 14, 2021–In a large study of pediatric cancer patients, researchers from Children’s Hospital of Philadelphia (CHOP) have analyzed the frequency, fusion partners, and clinical outcome of neurotrophic tyrosine receptor kinase (NTRK) fusions, which are clinical biomarkers that identify patients suitable for treatment with FDA-approved TRK inhibitors. The researchers found that NTRK fusions are…

Details

Is your skin thirsty? Optoacoustic sensor measures water content in living tissue

Researchers from Skoltech and the University of Texas Medical Branch (US) have shown how optoacoustics can be used for monitoring skin water content, a technique which is promising for medical applications such as tissue trauma management and in cosmetology. The paper outlining these results was published in the Journal of Biophotonics. (swelling caused by fluid…

Details